NASDAQ:LEGN
Legend Biotech
- Stock
Last Close
46.37
17/05 20:00
Market Cap
8.23B
Beta: −0.08
Volume Today
564.55K
Avg: 810.09K
PE Ratio
−39.80
PFCF: −29.36
Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|
asset turnover | 0.11 - | 0.20 73.80% | 0.10 47.26% | 0.08 23.50% | 0.09 9.49% | 0.15 75.46% | |
cash conversion cycle | -125.58 - | 199.44 258.81% | |||||
cash per share | 2.16 - | 1.59 26.49% | 4.28 169.88% | 6.26 46.37% | 6.45 2.94% | 7.43 15.28% | |
company equity multiplier | 49.61 - | -2.34 104.72% | 2.57 209.87% | 2.37 7.75% | 1.79 24.66% | 1.48 17.39% | |
days of inventory outstanding | 57.82 - | 43.08 25.50% | |||||
days of payables outstanding | 183.68 - | 44.69 75.67% | |||||
days of sales outstanding | 806.53 - | 227.91 71.74% | 409.90 79.85% | 256.76 37.36% | 0.28 99.89% | 201.05 71,508.99% | |
dividend yield | |||||||
ebit per revenue | -0.03 - | -2.29 7,219.98% | -4.14 81.18% | -4.38 5.71% | -3.90 11.00% | -1.55 60.19% | |
ebt per ebit | 1.05 - | 1.00 5.44% | 0.98 1.45% | 0.98 0.09% | 0.98 0.49% | 1.18 20.28% | |
effective tax rate | -0.72 - | -0.02 97.24% | 0.01 167.51% | -0.00 100.02% | -0.00 54,054.59% | 0.00 355.58% | |
enterprise value multiple | -487.95 - | -28.90 94.08% | -9.48 67.22% | -15.82 67.01% | -17.00 7.45% | -22.87 34.50% | |
fixed asset turnover | 1.48 - | 0.76 48.84% | 0.62 17.80% | 0.58 7.17% | 0.72 24.99% | 1.50 107.72% | |
free cash flow per share | 2.86 - | -1.22 142.64% | -2.31 89.28% | -1.74 24.48% | -1.40 19.83% | -2.87 105.58% | |
gross profit margin | 1 - | 1 0% | 1 0% | 1 0% | 0.44 55.86% | 0.42 4.27% | |
interest coverage | -18.71 - | -586.87 3,037.09% | -74.45 87.31% | -436.69 486.59% | -42.22 90.33% | -20.29 51.94% | |
inventory turnover | 6.31 - | 8.47 34.23% | |||||
long term debt to capitalization | 0.31 - | -0.04 113.71% | 0.01 115.76% | 0.21 2,940.92% | 0.27 33.20% | 0.18 33.02% | |
net income per ebt | 1.72 - | 1.02 40.80% | 0.99 3.28% | 1.00 1.37% | 1.00 0.14% | 1.00 0.50% | |
net profit margin | -0.06 - | -2.32 3,998.10% | -4.01 72.70% | -4.30 7.25% | -3.81 11.31% | -1.82 52.36% | |
operating cash flow per share | 3.07 - | -0.83 127.00% | -1.89 127.71% | -1.41 25.35% | -1.26 10.74% | -2.18 73.60% | |
operating cycle | 58.10 - | 244.12 320.18% | |||||
operating profit margin | -0.03 - | -2.29 7,219.98% | -4.14 81.18% | -4.38 5.71% | -3.90 11.00% | -1.55 60.19% | |
payables turnover | 1.99 - | 8.17 311.04% | |||||
pretax profit margin | -0.03 - | -2.28 6,821.94% | -4.06 78.55% | -4.30 5.81% | -3.81 11.43% | -1.82 52.12% | |
price fair value | 428.70 - | -30.18 107.04% | 11.87 139.34% | 13.93 17.36% | 10.67 23.44% | 8.47 20.63% | |
receivables turnover | 0.45 - | 1.60 253.87% | 0.89 44.40% | 1.42 59.64% | 1.30K 91,352.14% | 1.82 99.86% | |
return on assets | -0.01 - | -0.46 7,022.51% | -0.42 8.93% | -0.35 17.96% | -0.34 2.89% | -0.28 16.40% | |
return on capital employed | -0.01 - | -0.82 14,293.44% | -0.56 31.59% | -0.47 16.22% | -0.44 5.92% | -0.27 38.59% | |
return on equity | -0.32 - | 1.08 436.21% | -1.08 200.06% | -0.82 24.31% | -0.60 26.83% | -0.41 30.94% | |
total debt to capitalization | 0.33 - | -0.05 115.65% | 0.01 122.82% | 0.21 1,640.23% | 0.28 33.63% | 0.19 33.02% |
All numbers in USD (except ratios and percentages)